These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 30678221)

  • 41. Scorpiones, Scolopendra and Gekko Inhibit Lung Cancer Growth and Metastasis by Ameliorating Hypoxic Tumor Microenvironment via PI3K/AKT/mTOR/HIF-1α Signaling Pathway.
    Mao QY; Wang XQ; Lin F; Yu MW; Fan HT; Zheng Q; Liu LC; Zhang CC; Li DR; Lin HS
    Chin J Integr Med; 2024 Sep; 30(9):799-808. PubMed ID: 38850481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blocking Mammalian Target of Rapamycin (mTOR) Attenuates HIF-1α Pathways Engaged-Vascular Endothelial Growth Factor (VEGF) in Diabetic Retinopathy.
    Wei J; Jiang H; Gao H; Wang G
    Cell Physiol Biochem; 2016; 40(6):1570-1577. PubMed ID: 27997905
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
    Jin X; Jin HR; Lee D; Lee JH; Kim SK; Lee JJ
    Eur J Pharmacol; 2008 Sep; 592(1-3):41-7. PubMed ID: 18639543
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kamebakaurin inhibits the expression of hypoxia-inducible factor-1α and its target genes to confer antitumor activity.
    Wang KS; Ma J; Mi C; Li J; Lee JJ; Jin X
    Oncol Rep; 2016 Apr; 35(4):2045-52. PubMed ID: 26781327
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Q39, a quinoxaline 1,4-Di-N-oxide derivative, inhibits hypoxia-inducible factor-1α expression and the Akt/mTOR/4E-BP1 signaling pathway in human hepatoma cells.
    Weng Q; Zhang J; Cao J; Xia Q; Wang D; Hu Y; Sheng R; Wu H; Zhu D; Zhu H; He Q; Yang B
    Invest New Drugs; 2011 Dec; 29(6):1177-87. PubMed ID: 20524035
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 5,3'-Dihydroxy-6,7,4'-trimethoxyflavanone exerts its anticancer and antiangiogenesis effects through regulation of the Akt/mTOR signaling pathway in human lung cancer cells.
    Kim KM; Heo DR; Lee J; Park JS; Baek MG; Yi JM; Kim H; Bang OS
    Chem Biol Interact; 2015 Jan; 225():32-9. PubMed ID: 25446852
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of PI3K/Akt and MEK/ERK in mediating hypoxia-induced expression of HIF-1alpha and VEGF in laser-induced rat choroidal neovascularization.
    Yang XM; Wang YS; Zhang J; Li Y; Xu JF; Zhu J; Zhao W; Chu DK; Wiedemann P
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1873-9. PubMed ID: 19098317
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells.
    Fukuda R; Hirota K; Fan F; Jung YD; Ellis LM; Semenza GL
    J Biol Chem; 2002 Oct; 277(41):38205-11. PubMed ID: 12149254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reactive oxygen species regulate insulin-induced VEGF and HIF-1alpha expression through the activation of p70S6K1 in human prostate cancer cells.
    Zhou Q; Liu LZ; Fu B; Hu X; Shi X; Fang J; Jiang BH
    Carcinogenesis; 2007 Jan; 28(1):28-37. PubMed ID: 16774940
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of HIF-1α signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment.
    Frolova O; Samudio I; Benito JM; Jacamo R; Kornblau SM; Markovic A; Schober W; Lu H; Qiu YH; Buglio D; McQueen T; Pierce S; Shpall E; Konoplev S; Thomas D; Kantarjian H; Lock R; Andreeff M; Konopleva M
    Cancer Biol Ther; 2012 Aug; 13(10):858-70. PubMed ID: 22785211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha/VEGF signaling pathways in human breast cancer cells.
    Tang X; Zhang Q; Shi S; Yen Y; Li X; Zhang Y; Zhou K; Le AD
    Int J Cancer; 2010 Jan; 126(1):90-103. PubMed ID: 19569175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ginsenoside-Rg1 mediates a hypoxia-independent upregulation of hypoxia-inducible factor-1α to promote angiogenesis.
    Leung KW; Ng HM; Tang MK; Wong CC; Wong RN; Wong AS
    Angiogenesis; 2011 Dec; 14(4):515-22. PubMed ID: 21964931
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HIF-1α pathway: role, regulation and intervention for cancer therapy.
    Masoud GN; Li W
    Acta Pharm Sin B; 2015 Sep; 5(5):378-89. PubMed ID: 26579469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 4-O-methylascochlorin, methylated derivative of ascochlorin, stabilizes HIF-1α via AMPK activation.
    Jeong JH; Kang JH; Hwang SL; Cho HJ; Park KK; Park YY; Chung IK; Chang HW; Kim CH; Min KS; Kim HD; Magae J; Kang SS; Chang YC
    Biochem Biophys Res Commun; 2011 Mar; 406(3):353-8. PubMed ID: 21329651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Minocycline inhibits angiogenesis in vitro through the translational suppression of HIF-1α.
    Jung HJ; Seo I; Jha BK; Suh SI; Suh MH; Baek WK
    Arch Biochem Biophys; 2014 Mar; 545():74-82. PubMed ID: 24412777
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cryptotanshinone inhibits the growth and invasion of colon cancer by suppressing inflammation and tumor angiogenesis through modulating MMP/TIMP system, PI3K/Akt/mTOR signaling and HIF-1α nuclear translocation.
    Zhang L; Chen C; Duanmu J; Wu Y; Tao J; Yang A; Yin X; Xiong B; Gu J; Li C; Liu Z
    Int Immunopharmacol; 2018 Dec; 65():429-437. PubMed ID: 30388517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer.
    Cheng CW; Chen PM; Hsieh YH; Weng CC; Chang CW; Yao CC; Hu LY; Wu PE; Shen CY
    Oncotarget; 2015 Dec; 6(42):44222-38. PubMed ID: 26528854
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chlorogenic acid inhibits hypoxia-induced angiogenesis via down-regulation of the HIF-1α/AKT pathway.
    Park JJ; Hwang SJ; Park JH; Lee HJ
    Cell Oncol (Dordr); 2015 Apr; 38(2):111-8. PubMed ID: 25561311
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CCI-779 inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif-1alpha/VEGF signaling.
    Wan X; Shen N; Mendoza A; Khanna C; Helman LJ
    Neoplasia; 2006 May; 8(5):394-401. PubMed ID: 16790088
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Marked activity of irinotecan and rapamycin combination toward colon cancer cells in vivo and in vitro is mediated through cooperative modulation of the mammalian target of rapamycin/hypoxia-inducible factor-1alpha axis.
    Pencreach E; Guérin E; Nicolet C; Lelong-Rebel I; Voegeli AC; Oudet P; Larsen AK; Gaub MP; Guenot D
    Clin Cancer Res; 2009 Feb; 15(4):1297-307. PubMed ID: 19190131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.